Antibody - Humanisation, immunogenicity and developability assessment
Our bioinformatics-led approach to antibody humanisation finds the closest possible human-to-animal match and employs pattern recognition and machine learning to determine residues critical for antigen binding.
An integrated manufacturability assessment ensures leads have biophysical characteristics.
For larger scale production, our CHO-Flp/Frt targeted integration cell line will rapidly produce pre-clinical grade material.
Download the resource to read on...